Eren, O. C. Et Al. 2024. Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.. Annals of surgical oncology , vol.31, no.10 , 7001-7011.

Eren, O. C., Bagci, P., Balci, S., Ohike, N., Saka, B., Sokmensuer, C., ... Leblebici, C. B.(2024). Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.. Annals of surgical oncology , vol.31, no.10, 7001-7011.

Eren, Ozgur Et Al. "Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.," Annals of surgical oncology , vol.31, no.10, 7001-7011, 2024

Eren, Ozgur C. Et Al. "Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.." Annals of surgical oncology , vol.31, no.10, pp.7001-7011, 2024

Eren, O. C. Et Al. (2024) . "Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.." Annals of surgical oncology , vol.31, no.10, pp.7001-7011.

@article{article, author={Ozgur Can Eren Et Al. }, title={Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.}, journal={Annals of surgical oncology}, year=2024, pages={7001-7011} }